Sarcoidosis of the paranasal sinuses.


Journal

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
ISSN: 1434-4726
Titre abrégé: Eur Arch Otorhinolaryngol
Pays: Germany
ID NLM: 9002937

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 28 02 2019
accepted: 12 03 2019
pubmed: 23 3 2019
medline: 5 11 2019
entrez: 23 3 2019
Statut: ppublish

Résumé

Sarcoidosis is a chronic disease, which predominantly affects the lung. Since sinonasal sarcoidosis is rare, little is known about the sarcoidosis manifestation at this site. Therefore, the aim of our study was to detect the prevalence of sinonasal sarcoidosis, its clinical occurrence, diagnosis, and therapy. The database of all patients having visited the otorhinolaryngology departments of the universities in Göttingen and in Bonn between 2003 and 2016 was searched for the diagnosis of sinonasal sarcoidosis. Thirteen patients with a biopsy-proven sinonasal sarcoidosis were identified. Most patients presented non-specific clinical symptoms, which are also found in acute and chronic sinusitis. None of the patients was suspected to have sinonasal sarcoidosis by the ENT doctor before histological validation. The mean diagnostic delay was 262 (± 195) days. An additional pulmonary involvement was detected in four of six patients. Sinonasal sarcoidosis is presenting with heterogeneous clinical presentations. An early biopsy of granulomatous lesions is mandatory. A multidisciplinary approach is needed to exclude serious lung or heart manifestations, because even asymptomatic organ involvement is possible. A CT-scan may be useful even if unspecific. Local or systemic therapy has to be prepared individually using local and systemic corticosteroids, antimetabolites, or anti-TNF-alpha.

Sections du résumé

BACKGROUND BACKGROUND
Sarcoidosis is a chronic disease, which predominantly affects the lung. Since sinonasal sarcoidosis is rare, little is known about the sarcoidosis manifestation at this site. Therefore, the aim of our study was to detect the prevalence of sinonasal sarcoidosis, its clinical occurrence, diagnosis, and therapy.
METHODS METHODS
The database of all patients having visited the otorhinolaryngology departments of the universities in Göttingen and in Bonn between 2003 and 2016 was searched for the diagnosis of sinonasal sarcoidosis.
RESULTS RESULTS
Thirteen patients with a biopsy-proven sinonasal sarcoidosis were identified. Most patients presented non-specific clinical symptoms, which are also found in acute and chronic sinusitis. None of the patients was suspected to have sinonasal sarcoidosis by the ENT doctor before histological validation. The mean diagnostic delay was 262 (± 195) days. An additional pulmonary involvement was detected in four of six patients.
CONCLUSIONS CONCLUSIONS
Sinonasal sarcoidosis is presenting with heterogeneous clinical presentations. An early biopsy of granulomatous lesions is mandatory. A multidisciplinary approach is needed to exclude serious lung or heart manifestations, because even asymptomatic organ involvement is possible. A CT-scan may be useful even if unspecific. Local or systemic therapy has to be prepared individually using local and systemic corticosteroids, antimetabolites, or anti-TNF-alpha.

Identifiants

pubmed: 30900021
doi: 10.1007/s00405-019-05388-7
pii: 10.1007/s00405-019-05388-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1969-1974

Références

J Allergy Clin Immunol. 1999 May;103(5 Pt 1):789-95
pubmed: 10329811
Am J Respir Crit Care Med. 2006 Oct 1;174(7):795-802
pubmed: 16840744
Pneumologie. 1993 Oct;47(10):588-92
pubmed: 8259367
Eur Respir J. 1997 Dec;10(12):2699-700
pubmed: 9493645
Dtsch Arztebl Int. 2016 Aug 22;113(33-34):565-74
pubmed: 27598883
BMC Pulm Med. 2013 Sep 26;13:59
pubmed: 24070015
Otolaryngol Head Neck Surg. 1995 Feb;112(2):221-7
pubmed: 7838542
HNO. 2017 Aug;65(8):695-708
pubmed: 28710538
Head Neck Pathol. 2015 Jun;9(2):260-8
pubmed: 25183456
J Thorac Dis. 2017 Jan;9(1):88-95
pubmed: 28203410
Thorax. 2010 Feb;65(2):181-6
pubmed: 20147594
Radiographics. 2014 Sep-Oct;34(5):1240-56
pubmed: 25208278
Am J Rhinol Allergy. 2014 Jul-Aug;28(4):317-22
pubmed: 25197919
Head Neck Pathol. 2016 Mar;10(1):32-39
pubmed: 26830405
Pneumologie. 1995 Jun;49(6):378-82
pubmed: 7644459
Acta Pathol Jpn. 1993 Jul-Aug;43(7-8):372-6
pubmed: 8372682
Dtsch Med Wochenschr. 2017 Jan;142(1):17-23
pubmed: 28056473
Laryngoscope. 1983 Oct;93(10):1281-4
pubmed: 6621225
Chest. 2002 Jan;121(1):32-9
pubmed: 11796429
Sarcoidosis Vasc Diffuse Lung Dis. 1997 Sep;14(2):154-8
pubmed: 9306506
J Laryngol Otol. 1994 Aug;108(8):682-4
pubmed: 7930921
Am J Respir Crit Care Med. 2011 Jun 1;183(11):1446-7
pubmed: 21642253
HNO. 2007 Dec;55(12):956-60
pubmed: 17115091
AJNR Am J Neuroradiol. 2009 May;30(5):953-61
pubmed: 19193748
Sarcoidosis Vasc Diffuse Lung Dis. 1999 Sep;16(2):149-73
pubmed: 10560120
PLoS One. 2012;7(8):e43907
pubmed: 22952805
Laryngoscope. 2004 Nov;114(11):1960-3
pubmed: 15510022
Adv Exp Med Biol. 2017;980:1-9
pubmed: 28132132
Medicine (Baltimore). 2006 Nov;85(6):365-371
pubmed: 17108780
Ther Clin Risk Manag. 2016 Nov 07;12:1623-1634
pubmed: 27853374
Int Forum Allergy Rhinol. 2013 Jul;3(7):567-72
pubmed: 23307363
Eur Arch Otorhinolaryngol. 2010 Oct;267(10):1507-14
pubmed: 20617327
Otolaryngol Head Neck Surg. 2000 Oct;123(4):519-21
pubmed: 11020201
Otolaryngol Head Neck Surg. 1998 Jun;118(6):856-8
pubmed: 9627250
Eur Arch Otorhinolaryngol. 2010 Mar;267(3):381-4
pubmed: 19763596

Auteurs

Thorsten Send (T)

Department of Otorhinolaryngology, Head and Neck Surgery, University of Bonn, Sigmund-Freud-Str. 25, 53105, Bonn, Germany. thorsten.send@ukbonn.de.

Izabela Tuleta (I)

Department of Internal Medicine-Cardiology, University of Munster, Munster, Germany.

Tim Koppen (T)

Department of Otorhinolaryngology, Head and Neck Surgery, University of Bonn, Sigmund-Freud-Str. 25, 53105, Bonn, Germany.

Thore Thiesler (T)

Department of Pathology, University of Bonn, Bonn, Germany.

Klaus W Eichhorn (KW)

Department of Otorhinolaryngology, Head and Neck Surgery, University of Bonn, Sigmund-Freud-Str. 25, 53105, Bonn, Germany.

Mattis Bertlich (M)

Department of Otorhinolaryngology, Munich University (LMU), Munich, Germany.

Friedrich Bootz (F)

Department of Otorhinolaryngology, Head and Neck Surgery, University of Bonn, Sigmund-Freud-Str. 25, 53105, Bonn, Germany.

Mark Jakob (M)

Department of Otorhinolaryngology, Munich University (LMU), Munich, Germany.
Department of Otorhinolaryngology, University of Goettingen, Göttingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH